Novartis Halts Accord's Generic Heart Failure Drug Plans
A London court upheld Novartis' extended patent protections for heart failure drug Entresto on Thursday, blocking Accord's plans to launch a generic version of the treatment in the near future....To view the full article, register now.
Already a subscriber? Click here to view full article